ClinicalTrials.Veeva

Menu

Electronic Medical Record Alerts to Optimize Medical Therapy in Heart Failure and Reduced Ejection Fraction (OPTIMAL-HF)

I

Instituto Cardiovascular de Buenos Aires

Status

Not yet enrolling

Conditions

HFrEF - Heart Failure With Reduced Ejection Fraction

Treatments

Other: EMR alert

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

OPTIMAL-HF is a pragmatic, cluster randomized, single-blind intervention trial that will be conducted at an outpatient clinic in Argentina. The trial will assess the effectiveness of an individualized-based alert system compared to usual care in improving GDMT optimization at 90 days in patients with HFrEF.

Enrollment

240 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Patients

Inclusion Criteria:

  • Eligible patients will include those with an EF ≤ 40% on their most recent echocardiogram, age > 18, and an outpatient cardiology encounter during the study period.
  • Age 18 or over

Exclusion Criteria:

  • under optimal medical treatment
  • palliative care, or undergoing hemodialysis will be excluded

Cardiologist

Inclusion criteria:

Cardiologists from an outpatient clinic at a cardiovascular center in Buenos Aires will be selected for potential participation in the study.

Exclusion criteria Cardiologists belonging to the heart failure service

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

240 participants in 2 patient groups

EMR Alert
Experimental group
Treatment:
Other: EMR alert
Usual Care
No Intervention group

Trial contacts and locations

0

Loading...

Central trial contact

Lucrecia Burgos, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems